Myriad Genetics (MYGN) Return on Assets (2011 - 2026)

Myriad Genetics (MYGN) has reported Return on Assets for 16 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Assets declined to 0.01% in Q1 2026 per MYGN's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q1 2022 and bottomed at 0.01% in Q1 2026.
• Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
• On a YoY basis, Return on Assets climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
• Myriad Genetics' Return on Assets stood at 0.0% in 2022, then slumped by 147 bps to 0.0% in 2023, then surged by 47 bps to 0.0% in 2024, then sank by 323 bps to 0.01% in 2025, then slipped by 14 bps to 0.01% in 2026.
• Business Quant data shows MYGN's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.